GRIK2 and cancer: To expand our analyses of other fusion genes in the panel, we analyzed TRMT11-GRIK2, MTOR-TP53BP1, CCNH-C5orf30, KDM4-AC011523.2, TMEM135-CCDC67, and LRRC59-FLJ60017 in 20 cancer cell lines from six different human malignancies (Fig. 1).